Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
Discover why Eli Lilly's stock downturn may present new opportunities. Learn about valuation, Zepbound pricing, and 2026 ...
This is no reason to panic.
The share price has rallied over the past month.
18hon MSN
Where Will Eli Lilly Be in 10 Years?
In a decade, Eli Lilly could be in the same place that Pfizer finds itself in today.
The pharmaceutical stock can still deliver.
Why Eli Lilly Stock Keeps Pushing Higher Eli Lilly (LLY) has been grinding higher again, with shares up roughly 2% over the ...
Bank of America sees Eli Lilly's obesity drug growth underestimated, forecasting $3 billion Orfoglipron revenue by 2026 as ...
The average one-year price target for Eli Lilly and (NYSE:LLY) has been revised to $1,020.92 / share. This is an increase of 10.15% from the prior estimate of $926.82 dated November 7, 2025. The price ...
Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new ...
Calls have been more popular than usual in the options pits. LLY's 50-day call/put volume ratio of 2.23 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX ...
Eli Lilly just agreed to lower the price of its blockbuster GLP-1 weight loss drug. More than half of the company's revenue comes from just two weight loss drugs. Wall Street may be pricing in too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback